Progress of discoidin domain receptor 2 in tumors / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 357-360, 2017.
Article
em Zh
| WPRIM
| ID: wpr-609753
Biblioteca responsável:
WPRO
ABSTRACT
Discoidin domain receptor 2 (DDR2), a tyrosine kinase receptor belonging to DDRs family, is associated with progression of various cancers. Studies have indicated that DDR2 expression is upregulated in various cancer tissues, which could promote tumors proliferation, invasion, and metastases. Furthermore, patients with high DDR2 expression showed poor 5-year overall survival rate. In addition, DDR2 point mutation can enhance the sensitivity of tumor cells to small molecule tyrosine kinase inhibitor dasatinib, which suggests that DDR2 mutation may be a promising target for cancer therapy.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Cancer Research and Clinic
Ano de publicação:
2017
Tipo de documento:
Article